OS Therapies (OSTX) Stock: Buy, Sell, or Hold?
OSTX - OS Therapies Incorporated
$1.62
0.01 (0.62%)
▲
5d:
-2.41%
30d:
-5.26%
90d:
+0.62%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When OSTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OSTX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: OSTX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.28
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSTX is currently trading at $1.62, which is considered oversold relative to its 30-day fair value range of $1.63 to $1.80. The stock's valuation (Forward PE: 4.7) is in line with its historical norms (4.7). Remarkably, the market is currently pricing in an annual earnings decline of 0.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OSTX is in a uptrend. Immediate support is located at $1.56, while resistance sits at $1.84.
Market Sentiment: OSTX scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.50 (+424.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OSTX is in a uptrend. Immediate support is located at $1.56, while resistance sits at $1.84.
Market Sentiment: OSTX scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.50 (+424.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.63 -
$1.80
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 424.7% below Wall St target ($8.50)
- CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.63 -
$1.80
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.56
Resistance Level
$1.84
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.67
Wall Street Target
$8.50
(+424.7%)
Valuation Discount vs History
-0.4% cheaper
PE vs Historical
4.7 vs 4.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.4%
(market-implied from PE analysis)
1-Year Target
$1.61
(0%)
2-Year Target
$1.61
(-1%)
3-Year Target
$1.60
(-1%)
3-Yr Target (if PE normalizes)
(PE: 5→5)
$1.61
(-1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.7 to 4.7
Stabilization Target:
$1.63
(+0.6%)
PE Expansion Potential:
+0.6%
Share & Embed Analysis
Last updated: October 04, 2026 2:22 AM ET
Data refreshes hourly during market hours. Next update: 3:22 AM
Data refreshes hourly during market hours. Next update: 3:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
